Emergency or routine vaccination against meningococcal disease in Africa?

Lancet

Volumn 355, Issue 9197, 2000, Pages 3-

  Peltola, Heikki ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

MENINGOCOCCUS VACCINE;

AFRICA; EMERGENCY TREATMENT; HUMAN; MENINGOCOCCOSIS; NOTE; PRIORITY JOURNAL; VACCINATION;

EID: 0343415526     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(99)00389-X     Document Type: Note

References (9)

1. Lapeyssonnie L. La méningite cérébro-spinale en Afrique. Bull World Health Organ. 28 (suppl):1963;1-114.
2. Hume S.E. Mass voluntary immunization campaigns for meningococcal disease in Canada: media hysteria. JAMA. 267:1992;1833-1838.
3. Greenwood B.M., Wali S.S. Control of meningococcal infection in the African meningitis belt by selective vaccination. Lancet. i:1980;729-732.
4. Peltola H. Meningococcal vaccines. Current status and future possibilities. Drugs. 55:1998;347-366.
5. WHO Working Group. Control of meningococcal disease. WHO practical guidelines. Lyon: WHO and Fondation Marcel Mérieux, 1995.
6. Abbasi K. Free the slaves. Debt relief for the world's poorest is feasible but may not happen. BMJ. 318:1999;1568-1569.
7. Torres E.M., Alvarez G.A., Rodríguez R.M.et al. Los cambios en la distribucion segun la edad, como factor de prediccion epidemica en la enfermedad meningococica. Rev Cub Pediatr. 59:1987;773-783.
8. Serogroup B meningococcal disease - Oregon, 1994. MMWR Morb Mortal Wkly Rep. 44:1995;121-124.
9. Peltola H., Kataja M.A., Mäkelä P.H. Shift in the age-distribution of meningococcal diseases as predictor of an epidemic? Lancet. ii:1982;595-597.